Ligand validation:6W8C

R16: HEXADECANE

R16 is a Ligand Of Interest in 6W8C designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6W8C_R16_A_405	36%	71%	0.136	0.827	0.37	0.72	-	-	0	0	100%	1
6W8C_R16_A_406	34%	73%	0.153	0.834	0.35	0.7	-	-	0	0	100%	1
6W8C_R16_A_407	4%	76%	0.301	0.663	0.37	0.58	-	-	0	0	100%	1
6W86_R16_B_405	28%	76%	0.166	0.819	0.47	0.47	-	-	0	0	100%	1
8UE9_R16_A_601	23%	88%	0.215	0.838	0.3	0.36	-	-	0	0	100%	1
8UE2_R16_A_407	18%	69%	0.229	0.818	0.31	0.85	-	-	0	0	100%	1
6W7D_R16_B_408	1%	70%	0.207	0.387	0.3	0.85	-	-	0	0	100%	1
6S6C_R16_A_302	63%	99%	0.088	0.88	0.11	0.13	-	-	2	0	100%	1
7VSO_R16_A_310	32%	65%	0.226	0.9	0.24	1.08	-	1	0	0	100%	1
3HAP_R16_A_411	31%	0%	0.142	0.811	7.28	11.83	15	14	0	0	100%	1
3HAS_R16_A_404	22%	0%	0.172	0.785	5.09	9.76	15	14	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.